Literature DB >> 19697648

The prevalence of clinical diagnostic groups in patients with temporomandibular disorders.

Luciana Pimenta e Silva Machado1, Cláudio de Góis Nery, Cláudio Rodrigues Leles, Marianita Batista de Macedo Nery, Jeffrey P Okeson.   

Abstract

The aim of this study was to observe the prevalence of diagnostic groups of temporomandibular disorders (TMD) in patients who were referred or sought treatment for TMD and/or orofacial pain in a private clinic. The clinical records of 357 patients were evaluated and selected based on inclusion/exclusion criteria; the mean age was 32 years. A clinical examination was performed and the diagnosis was based on the American Academy of Orofacial Pain criteria. Results showed that 86.8% of patients were women and 93.3% of the patients presented more than one diagnosis. The most frequent chief complaint (n = 216, chi2 = 30.68, p = 0.001) and total diagnosis realized (n = 748, chi2 = 14.14, p = 0.001) were muscle related. We concluded that women seek treatment for dysfunction/disorders of orofacial structures more than men do; patients seeking specialized treatment have more than one diagnosis and muscle dysfunction is more prevalent than intra-articular disorders.

Entities:  

Mesh:

Year:  2009        PMID: 19697648     DOI: 10.1179/crn.2009.029

Source DB:  PubMed          Journal:  Cranio        ISSN: 0886-9634            Impact factor:   2.020


  13 in total

1.  Photobiomodulation-induced analgesia in experimental temporomandibular disorder involves central inhibition of fractalkine.

Authors:  João Ignácio Ferrara-Jr; Everton Tiago de Souza; Adriano Cardozo Franciosi; Elaine Flamia Toniolo; Camila Squarzoni Dale
Journal:  Lasers Med Sci       Date:  2019-04-10       Impact factor: 3.161

Review 2.  Current panorama of temporomandibular disorders' field in Brazil.

Authors:  Naila Aparecida de Godoi Machado; Fernanda Ferruzzi Lima; Paulo César Rodrigues Conti
Journal:  J Appl Oral Sci       Date:  2014-06       Impact factor: 2.698

3.  A clinically relevant animal model of temporomandibular disorder and irritable bowel syndrome comorbidity.

Authors:  Richard J Traub; Dong-Yuan Cao; Jane Karpowicz; Sangeeta Pandya; Yaping Ji; Susan G Dorsey; Dean Dessem
Journal:  J Pain       Date:  2014-06-26       Impact factor: 5.820

4.  Repeated muscle injury as a presumptive trigger for chronic masticatory muscle pain.

Authors:  Dean Dessem; Richard M Lovering
Journal:  Pain Res Treat       Date:  2011-06-12

5.  Videofluoroscopic evaluation of mastication and swallowing in individuals with TMD.

Authors:  Carla Maffei; Marçal Motta de Mello; Noemi Grigoletto de Biase; Lilian Pasetti; Paulo A Monteiro Camargo; Kelly Cristina Alves Silvério; Maria Inês Rebelo Gonçalves
Journal:  Braz J Otorhinolaryngol       Date:  2012 Jul-Aug

6.  Temporomandibular disorders and oral parafunctions: mechanism, diagnostics, and therapy.

Authors:  Klaus Boening; Mieszko Wieckiewicz; Anna Paradowska-Stolarz; Piotr Wiland; Yuh-Yuan Shiau
Journal:  Biomed Res Int       Date:  2015-05-14       Impact factor: 3.411

7.  Profiling the clinical presentation of diagnostic characteristics of a sample of symptomatic TMD patients.

Authors:  Luciana Pimenta e Silva Machado; Marianita Batista de Macedo Nery; Cláudio de Góis Nery; Cláudio Rodrigues Leles
Journal:  BMC Oral Health       Date:  2012-08-02       Impact factor: 2.757

8.  TRPV1 channel-mediated bilateral allodynia induced by unilateral masseter muscle inflammation in rats.

Authors:  Suncana Simonic-Kocijan; Xuehong Zhao; Wen Liu; Yuwei Wu; Ivone Uhac; KeWei Wang
Journal:  Mol Pain       Date:  2013-12-30       Impact factor: 3.395

9.  Evaluation of salivary cortisol and anxiety levels in myofascial pain dysfunction syndrome.

Authors:  Lakshmi Kavitha Nadendla; Venkateswarlu Meduri; Geetha Paramkusam; Koteswara Rao Pachava
Journal:  Korean J Pain       Date:  2013-12-31

10.  Type of intractable temporomandibular disorder and treatment protocols.

Authors:  Young-Kyun Kim
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2014-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.